Table 1 Patient characteristics
| Â | Intention-to-treat | CRT-S |
|---|---|---|
Number of patients, n | 130 | 119 |
Age at diagnosis, mean (range) | 55 (25–82) | 53 (25–80) |
Follow-up in months, mean (range) | 48 (4.73–170.57) | 53 (7.30–170.57) |
Histology | ||
 Adenocarcinoma | 23 (18%) | 23 (19%) |
 Squamous cell carcinoma | 107 (82%) | 97 (81%) |
Tumor size in cm, mean (range) | 5.1 (1.5–11.7) | 4.7 (1.5–11.7) |
FIGO 2009 | ||
 I | 12 (9%) | 12 (10%) |
 II | 85 (65%) | 80 (67%) |
 III | 22 (17%) | 19 (16%) |
 IV | 11 (9%) | 8 (7%) |
FIGO 2018 | ||
 IB3 | 4 (3%) | 4 (3%) |
 II | 49 (38%) | 46 (39%) |
 III | 64 (49%) | 59 (50%) |
 IV | 13 (10%) | 10 (8%) |
Chemotherapy | 120 (92%) | 112 (94%) |
Positive lymph nodes | 66 (51%) | 63 (53%) |
 Iliac artery | 57 | 54 |
 Inguinal | 2 | 2 |
 Para-aortic | 7 | 7 |
Clinical complete response, n (%) | 43 (33%) | 43 (36%) |
Iconographic complete response, n (%) | 59 (45%) | 56 (47%) |
Cancer-related deaths, n (%) | 30 (23%) | 22 (18%) |